ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Oncology Drugs Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-1N16087
Home | Market Reports | Health| Health Conditions| Cancer
Global and India Oncology Drugs Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Oncology Drugs Market Report & Forecast 2023-2029

Code: QYRE-Auto-1N16087
Report
November 2023
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Group
Roche
Celgene
Novartis
Bristol–Myers Squibb
Johnson & Johnson
Merck
Astrazeneca plc
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Sanofi
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences

and India Oncology Drugs Market Size

The global Oncology Drugs revenue was US$ 197440 million in 2022 and is forecast to a readjusted size of US$ 395270 million by 2029 with a CAGR of 10.3% during the review period (2023-2029).

and India Oncology Drugs Market

and India Oncology Drugs Market

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
In India, the Oncology Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
This report focuses on global and India Oncology Drugs market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Oncology Drugs will continue to grow rapidly in the future.
Global Oncology Drugs Scope and Market Size
Oncology Drugs market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Oncology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Oncology Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Oncology Drugs Market Report

Report Metric Details
Report Name and India Oncology Drugs Market
Forecasted market size in 2029 US$ 395270 million
CAGR 10.3%
Forecasted years 2023 - 2029
Segment by Type
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
Segment by Application
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Oncology Drugs Market size in 2029?

Ans: The and India Oncology Drugs Market size in 2029 will be US$ 395270 million.

What is the Roche, Celgene, Novartis share in and India Oncology Drugs Market?

Ans: The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues.

What is the and India Oncology Drugs Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Oncology Drugs Market report?

Ans: The main players in the and India Oncology Drugs Market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences

What are the Application segmentation covered in the and India Oncology Drugs Market report?

Ans: The Applications covered in the and India Oncology Drugs Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory or Lung Cancer, Others

What are the Type segmentation covered in the and India Oncology Drugs Market report?

Ans: The Types covered in the and India Oncology Drugs Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

1 Study Coverage
1.1 Oncology Drugs Product Introduction
1.2 Global Oncology Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global Oncology Drugs Market Size for the Year 2018-2029
1.2.2 India Oncology Drugs Market Size for the Year 2018-2029
1.3 Oncology Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Oncology Drugs in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Oncology Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Oncology Drugs Market Dynamics
1.4.1 Oncology Drugs Industry Trends
1.4.2 Oncology Drugs Market Drivers
1.4.3 Oncology Drugs Market Challenges
1.4.4 Oncology Drugs Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Oncology Drugs by Type
2.1 Oncology Drugs Market Segment by Type
2.1.1 Chemotherapy
2.1.2 Targeted Therapy
2.1.3 Immunotherapy (Biologic Therapy)
2.1.4 Hormonal Therapy
2.1.5 Others
2.2 Global Oncology Drugs Market Size by Type (2018, 2022 & 2029)
2.3 Global Oncology Drugs Market Size by Type (2018-2029)
2.4 India Oncology Drugs Market Size by Type (2018, 2022 & 2029)
2.5 India Oncology Drugs Market Size by Type (2018-2029)
3 Oncology Drugs by Application
3.1 Oncology Drugs Market Segment by Application
3.1.1 Blood Cancer
3.1.2 Breast Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Prostate Cancer
3.1.5 Respiratory or Lung Cancer
3.1.6 Others
3.2 Global Oncology Drugs Market Size by Application (2018, 2022 & 2029)
3.3 Global Oncology Drugs Market Size by Application (2018-2029)
3.4 India Oncology Drugs Market Size by Application (2018, 2022 & 2029)
3.5 India Oncology Drugs Market Size by Application (2018-2029)
4 Global Oncology Drugs Competitor Landscape by Company
4.1 Global Oncology Drugs Market Size by Company
4.1.1 Global Key Companies of Oncology Drugs, Ranked by Revenue (2022)
4.1.2 Global Oncology Drugs Revenue by Player (2018-2023)
4.2 Global Oncology Drugs Concentration Ratio (CR)
4.2.1 Oncology Drugs Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Oncology Drugs in 2022
4.2.3 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Oncology Drugs Head office and Area Served
4.4 Global Key Players of Oncology Drugs, Product and Application
4.5 Global Key Players of Oncology Drugs, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Oncology Drugs Market Size by Company
4.7.1 Key Players of Oncology Drugs in India, Ranked by Revenue (2022)
4.7.2 India Oncology Drugs Revenue by Players (2021, 2022 & 2023)
5 Global Oncology Drugs Market Size by Region
5.1 Global Oncology Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Oncology Drugs Market Size by Region (2018-2029)
5.2.1 Global Oncology Drugs Market Size by Region: 2018-2023
5.2.2 Global Oncology Drugs Market Size by Region (2024-2029)
6 Americas
6.1 Americas Oncology Drugs Market Size YoY Growth 2018-2029
6.2 Americas Oncology Drugs Market Size by Type
6.2.1 Americas Oncology Drugs Market Size by Type (2018-2023)
6.2.2 Americas Oncology Drugs Market Size by Type (2024-2029)
6.2.3 Americas Oncology Drugs Market Share by Type (2018-2029)
6.3 Americas Oncology Drugs Market Size by Application
6.3.1 Americas Oncology Drugs Market Size by Application (2018-2023)
6.3.2 Americas Oncology Drugs Market Size by Application (2024-2029)
6.3.3 Americas Oncology Drugs Market Share by Application (2018-2029)
6.4 Americas Oncology Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Oncology Drugs Market Size YoY Growth 2018-2029
7.2 EMEA Oncology Drugs Market Size by Type
7.2.1 EMEA Oncology Drugs Market Size by Type (2018-2023)
7.2.2 EMEA Oncology Drugs Market Size by Type (2024-2029)
7.2.3 EMEA Oncology Drugs Market Share by Type (2018-2029)
7.3 EMEA Oncology Drugs Market Size by Application
7.3.1 EMEA Oncology Drugs Market Size by Application (2018-2023)
7.3.2 EMEA Oncology Drugs Market Size by Application (2024-2029)
7.3.3 EMEA Oncology Drugs Market Share by Application (2018-2029)
7.4 EMEA Oncology Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Oncology Drugs Market Size YoY Growth 2018-2029
8.2 China Oncology Drugs Market Size by Type
8.2.1 China Oncology Drugs Market Size by Type (2018-2023)
8.2.2 China Oncology Drugs Market Size by Type (2024-2029)
8.2.3 China Oncology Drugs Market Share by Type (2018-2029)
8.3 China Oncology Drugs Market Size by Application
8.3.1 China Oncology Drugs Market Size by Application (2018-2023)
8.3.2 China Oncology Drugs Market Size by Application (2024-2029)
8.3.3 China Oncology Drugs Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Oncology Drugs Market Size YoY Growth 2018-2029
9.2 APAC Oncology Drugs Market Size by Type
9.2.1 APAC Oncology Drugs Market Size by Type (2018-2023)
9.2.2 APAC Oncology Drugs Market Size by Type (2024-2029)
9.2.3 APAC Oncology Drugs Market Share by Type (2018-2029)
9.3 APAC Oncology Drugs Market Size by Application
9.3.1 APAC Oncology Drugs Market Size by Application (2018-2023)
9.3.2 APAC Oncology Drugs Market Size by Application (2024-2029)
9.3.3 APAC Oncology Drugs Market Share by Application (2018-2029)
9.4 APAC Oncology Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Roche
10.1.1 Roche Company Details
10.1.2 Roche Business Overview
10.1.3 Roche Oncology Drugs Introduction
10.1.4 Roche Revenue in Oncology Drugs Business (2018-2023)
10.1.5 Roche Recent Development
10.2 Celgene
10.2.1 Celgene Company Details
10.2.2 Celgene Business Overview
10.2.3 Celgene Oncology Drugs Introduction
10.2.4 Celgene Revenue in Oncology Drugs Business (2018-2023)
10.2.5 Celgene Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Novartis Business Overview
10.3.3 Novartis Oncology Drugs Introduction
10.3.4 Novartis Revenue in Oncology Drugs Business (2018-2023)
10.3.5 Novartis Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Details
10.4.2 Bristol-Myers Squibb Business Overview
10.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
10.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2018-2023)
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Details
10.5.2 Johnson & Johnson Business Overview
10.5.3 Johnson & Johnson Oncology Drugs Introduction
10.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2018-2023)
10.5.5 Johnson & Johnson Recent Development
10.6 Merck & Co.
10.6.1 Merck & Co. Company Details
10.6.2 Merck & Co. Business Overview
10.6.3 Merck & Co. Oncology Drugs Introduction
10.6.4 Merck & Co. Revenue in Oncology Drugs Business (2018-2023)
10.6.5 Merck & Co. Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Details
10.7.2 AstraZeneca Business Overview
10.7.3 AstraZeneca Oncology Drugs Introduction
10.7.4 AstraZeneca Revenue in Oncology Drugs Business (2018-2023)
10.7.5 AstraZeneca Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Details
10.8.2 Pfizer Business Overview
10.8.3 Pfizer Oncology Drugs Introduction
10.8.4 Pfizer Revenue in Oncology Drugs Business (2018-2023)
10.8.5 Pfizer Recent Development
10.9 Amgen
10.9.1 Amgen Company Details
10.9.2 Amgen Business Overview
10.9.3 Amgen Oncology Drugs Introduction
10.9.4 Amgen Revenue in Oncology Drugs Business (2018-2023)
10.9.5 Amgen Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Details
10.10.2 Eli Lilly Business Overview
10.10.3 Eli Lilly Oncology Drugs Introduction
10.10.4 Eli Lilly Revenue in Oncology Drugs Business (2018-2023)
10.10.5 Eli Lilly Recent Development
10.11 AbbVie
10.11.1 AbbVie Company Details
10.11.2 AbbVie Business Overview
10.11.3 AbbVie Oncology Drugs Introduction
10.11.4 AbbVie Revenue in Oncology Drugs Business (2018-2023)
10.11.5 AbbVie Recent Development
10.12 Takeda
10.12.1 Takeda Company Details
10.12.2 Takeda Business Overview
10.12.3 Takeda Oncology Drugs Introduction
10.12.4 Takeda Revenue in Oncology Drugs Business (2018-2023)
10.12.5 Takeda Recent Development
10.13 Astellas
10.13.1 Astellas Company Details
10.13.2 Astellas Business Overview
10.13.3 Astellas Oncology Drugs Introduction
10.13.4 Astellas Revenue in Oncology Drugs Business (2018-2023)
10.13.5 Astellas Recent Development
10.14 Ipsen
10.14.1 Ipsen Company Details
10.14.2 Ipsen Business Overview
10.14.3 Ipsen Oncology Drugs Introduction
10.14.4 Ipsen Revenue in Oncology Drugs Business (2018-2023)
10.14.5 Ipsen Recent Development
10.15 Sanofi
10.15.1 Sanofi Company Details
10.15.2 Sanofi Business Overview
10.15.3 Sanofi Oncology Drugs Introduction
10.15.4 Sanofi Revenue in Oncology Drugs Business (2018-2023)
10.15.5 Sanofi Recent Development
10.16 Bayer
10.16.1 Bayer Company Details
10.16.2 Bayer Business Overview
10.16.3 Bayer Oncology Drugs Introduction
10.16.4 Bayer Revenue in Oncology Drugs Business (2018-2023)
10.16.5 Bayer Recent Development
10.17 Biogen Idec
10.17.1 Biogen Idec Company Details
10.17.2 Biogen Idec Business Overview
10.17.3 Biogen Idec Oncology Drugs Introduction
10.17.4 Biogen Idec Revenue in Oncology Drugs Business (2018-2023)
10.17.5 Biogen Idec Recent Development
10.18 Teva
10.18.1 Teva Company Details
10.18.2 Teva Business Overview
10.18.3 Teva Oncology Drugs Introduction
10.18.4 Teva Revenue in Oncology Drugs Business (2018-2023)
10.18.5 Teva Recent Development
10.19 Otsuka
10.19.1 Otsuka Company Details
10.19.2 Otsuka Business Overview
10.19.3 Otsuka Oncology Drugs Introduction
10.19.4 Otsuka Revenue in Oncology Drugs Business (2018-2023)
10.19.5 Otsuka Recent Development
10.20 Eisai
10.20.1 Eisai Company Details
10.20.2 Eisai Business Overview
10.20.3 Eisai Oncology Drugs Introduction
10.20.4 Eisai Revenue in Oncology Drugs Business (2018-2023)
10.20.5 Eisai Recent Development
10.21 Merck KGaA
10.21.1 Merck KGaA Company Details
10.21.2 Merck KGaA Business Overview
10.21.3 Merck KGaA Oncology Drugs Introduction
10.21.4 Merck KGaA Revenue in Oncology Drugs Business (2018-2023)
10.21.5 Merck KGaA Recent Development
10.22 Gilead Sciences
10.22.1 Gilead Sciences Company Details
10.22.2 Gilead Sciences Business Overview
10.22.3 Gilead Sciences Oncology Drugs Introduction
10.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2018-2023)
10.22.5 Gilead Sciences Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Group
Roche
Celgene
Novartis
Bristol–Myers Squibb
Johnson & Johnson
Merck
Astrazeneca plc
Pfizer Inc
Amgen Inc
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen S A
Sanofi
Bayer
Biogen Idec
TEVA
Otsuka
Eisai Co Ltd
Merck KGaA
Gilead Sciences
List of Tables
    Table 1. Oncology Drugs Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Oncology Drugs Market Trends
    Table 3. Oncology Drugs Market Drivers
    Table 4. Oncology Drugs Market Challenges
    Table 5. Oncology Drugs Market Restraints
    Table 6. Global Oncology Drugs Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Oncology Drugs Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Oncology Drugs Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Oncology Drugs Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Oncology Drugs, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Oncology Drugs Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Oncology Drugs Revenue Share by Player, 2018-2023
    Table 13. Global Oncology Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2022)
    Table 15. Global Key Players of Oncology Drugs, Headquarters and Area Served
    Table 16. Global Key Players of Oncology Drugs, Product and Application
    Table 17. Global Key Players of Oncology Drugs, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Oncology Drugs in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Oncology Drugs Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Oncology Drugs Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Oncology Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Oncology Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Oncology Drugs Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Oncology Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Oncology Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Oncology Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Oncology Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Oncology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Oncology Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Oncology Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Oncology Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Oncology Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Oncology Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Oncology Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Oncology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Oncology Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Oncology Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Oncology Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Oncology Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Oncology Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Oncology Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Oncology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Oncology Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Oncology Drugs Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Oncology Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Oncology Drugs Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Oncology Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Oncology Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Oncology Drugs Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Roche Company Details
    Table 52. Roche Business Overview
    Table 53. Roche Oncology Drugs Product
    Table 54. Roche Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 55. Roche Recent Development
    Table 56. Celgene Company Details
    Table 57. Celgene Business Overview
    Table 58. Celgene Oncology Drugs Product
    Table 59. Celgene Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 60. Celgene Recent Development
    Table 61. Novartis Company Details
    Table 62. Novartis Business Overview
    Table 63. Novartis Oncology Drugs Product
    Table 64. Novartis Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 65. Novartis Recent Development
    Table 66. Bristol-Myers Squibb Company Details
    Table 67. Bristol-Myers Squibb Business Overview
    Table 68. Bristol-Myers Squibb Oncology Drugs Product
    Table 69. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 70. Bristol-Myers Squibb Recent Development
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Oncology Drugs Product
    Table 74. Johnson & Johnson Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 75. Johnson & Johnson Recent Development
    Table 76. Merck & Co. Company Details
    Table 77. Merck & Co. Business Overview
    Table 78. Merck & Co. Oncology Drugs Product
    Table 79. Merck & Co. Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 80. Merck & Co. Recent Development
    Table 81. AstraZeneca Company Details
    Table 82. AstraZeneca Business Overview
    Table 83. AstraZeneca Oncology Drugs Product
    Table 84. AstraZeneca Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 85. AstraZeneca Recent Development
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer Oncology Drugs Product
    Table 89. Pfizer Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 90. Pfizer Recent Development
    Table 91. Amgen Company Details
    Table 92. Amgen Business Overview
    Table 93. Amgen Oncology Drugs Product
    Table 94. Amgen Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 95. Amgen Recent Development
    Table 96. Eli Lilly Company Details
    Table 97. Eli Lilly Business Overview
    Table 98. Eli Lilly Oncology Drugs Product
    Table 99. Eli Lilly Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 100. Eli Lilly Recent Development
    Table 101. AbbVie Company Details
    Table 102. AbbVie Business Overview
    Table 103. AbbVie Oncology Drugs Product
    Table 104. AbbVie Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 105. AbbVie Recent Development
    Table 106. Takeda Company Details
    Table 107. Takeda Business Overview
    Table 108. Takeda Oncology Drugs Product
    Table 109. Takeda Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 110. Takeda Recent Development
    Table 111. Astellas Company Details
    Table 112. Astellas Business Overview
    Table 113. Astellas Oncology Drugs Product
    Table 114. Astellas Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 115. Astellas Recent Development
    Table 116. Ipsen Company Details
    Table 117. Ipsen Business Overview
    Table 118. Ipsen Oncology Drugs Product
    Table 119. Ipsen Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 120. Ipsen Recent Development
    Table 121. Sanofi Company Details
    Table 122. Sanofi Business Overview
    Table 123. Sanofi Oncology Drugs Product
    Table 124. Sanofi Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 125. Sanofi Recent Development
    Table 126. Bayer Company Details
    Table 127. Bayer Business Overview
    Table 128. Bayer Oncology Drugs Product
    Table 129. Bayer Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 130. Bayer Recent Development
    Table 131. Biogen Idec Company Details
    Table 132. Biogen Idec Business Overview
    Table 133. Biogen Idec Oncology Drugs Product
    Table 134. Biogen Idec Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 135. Biogen Idec Recent Development
    Table 136. Teva Company Details
    Table 137. Teva Business Overview
    Table 138. Teva Oncology Drugs Product
    Table 139. Teva Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 140. Teva Recent Development
    Table 141. Otsuka Company Details
    Table 142. Otsuka Business Overview
    Table 143. Otsuka Oncology Drugs Product
    Table 144. Otsuka Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 145. Otsuka Recent Development
    Table 146. Eisai Company Details
    Table 147. Eisai Business Overview
    Table 148. Eisai Oncology Drugs Product
    Table 149. Eisai Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 150. Eisai Recent Development
    Table 151. Merck KGaA Company Details
    Table 152. Merck KGaA Business Overview
    Table 153. Merck KGaA Oncology Drugs Product
    Table 154. Merck KGaA Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 155. Merck KGaA Recent Development
    Table 156. Gilead Sciences Company Details
    Table 157. Gilead Sciences Business Overview
    Table 158. Gilead Sciences Oncology Drugs Product
    Table 159. Gilead Sciences Revenue in Oncology Drugs Business (2018-2023) & (US$ Million)
    Table 160. Gilead Sciences Recent Development
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology Drugs Product Picture
    Figure 2. Global Oncology Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Oncology Drugs Market Size 2018-2029 (US$ Million)
    Figure 4. India Oncology Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Oncology Drugs Market Size 2018-2029 (US$ Million)
    Figure 6. India Oncology Drugs Market Share in Global 2018-2029
    Figure 7. Oncology Drugs Report Years Considered
    Figure 8. Product Picture of Chemotherapy
    Figure 9. Product Picture of Targeted Therapy
    Figure 10. Product Picture of Immunotherapy (Biologic Therapy)
    Figure 11. Product Picture of Hormonal Therapy
    Figure 12. Product Picture of Others
    Figure 13. Global Oncology Drugs Market Share by Type in 2022 & 2029
    Figure 14. Global Oncology Drugs Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. Global Oncology Drugs Market Share by Type (2018-2029)
    Figure 16. India Oncology Drugs Market Share by Type in 2022 & 2029
    Figure 17. India Oncology Drugs Market Size by Type (2018-2029) & (US$ Million)
    Figure 18. India Oncology Drugs Market Share by Type (2018-2029)
    Figure 19. Product Picture of Blood Cancer
    Figure 20. Product Picture of Breast Cancer
    Figure 21. Product Picture of Gastrointestinal Cancer
    Figure 22. Product Picture of Prostate Cancer
    Figure 23. Product Picture of Respiratory or Lung Cancer
    Figure 24. Product Picture of Others
    Figure 25. Global Oncology Drugs Market Share by Application in 2022 & 2029
    Figure 26. Global Oncology Drugs Market Size by Application (2018-2029) & (US$ Million)
    Figure 27. Global Oncology Drugs Market Share by Application (2018-2029)
    Figure 28. India Oncology Drugs Market Share by Application in 2022 & 2029
    Figure 29. India Oncology Drugs Market Size by Application (2018-2029) & (US$ Million)
    Figure 30. India Oncology Drugs Market Share by Application (2018-2029)
    Figure 31. The Top 5 and 10 Largest Companies of Oncology Drugs in the World: Market Share by Oncology Drugs Revenue in 2022
    Figure 32. Global Oncology Drugs Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 33. Global Oncology Drugs Market Share by Region (2018-2029)
    Figure 34. Americas Oncology Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 35. Americas Oncology Drugs Market Share by Type (2018-2029)
    Figure 36. Americas Oncology Drugs Market Share by Application (2018-2029)
    Figure 37. United States Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Canada Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Mexico Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Brazil Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. EMEA Oncology Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 42. EMEA Oncology Drugs Market Share by Type (2018-2029)
    Figure 43. EMEA Oncology Drugs Market Share by Application (2018-2029)
    Figure 44. Europe Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Middle East Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Africa Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 47. China Oncology Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 48. China Oncology Drugs Market Share by Type (2018-2029)
    Figure 49. China Oncology Drugs Market Share by Application (2018-2029)
    Figure 50. APAC Oncology Drugs Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 51. APAC Oncology Drugs Market Share by Type (2018-2029)
    Figure 52. APAC Oncology Drugs Market Share by Application (2018-2029)
    Figure 53. Japan Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. South Korea Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 55. China Taiwan Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Southeast Asia Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 57. India Oncology Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 59. Celgene Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 60. Novartis Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 63. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 64. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 65. Pfizer Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 66. Amgen Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 67. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 68. AbbVie Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 69. Takeda Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 70. Astellas Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 71. Ipsen Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 72. Sanofi Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 73. Bayer Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 74. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 75. Teva Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 76. Otsuka Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 77. Eisai Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 78. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 79. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2018-2023)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Robotic Radiotherapy Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22E17264
Thu Oct 30 00:00:00 UTC 2025

Add to Cart

Global Brachytherapy C-Arm Tables Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22H17272
Thu Oct 30 00:00:00 UTC 2025

Add to Cart

Global Copper-zinc Superoxide Dismutase ( Cu-Zn-SOD) Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-26X17105
Wed Oct 29 00:00:00 UTC 2025

Add to Cart

Global TCR-T Cellular Immunotherapy Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-17O17547
Wed Oct 29 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions